Cargando…
SAT-368 CYP24A1 Mutation Masking Malignancy Mediated Hypercalcemia
Background: Mutations in CYP24A1, resulting in reduced conversion of 1,25(OH)(2)D to its inactive metabolite 24,25-(OH)(2)D(3),are rare causes of parathyroid hormone (PTH)-independent hypercalcemia. While manifestations may range from the severe idiopathic infantile hypercalcemia due to biallelic mu...
Autores principales: | Cheng, Cheng, Liu, Chienying, Bikle, Daniel D, Shoback, Dolores M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208999/ http://dx.doi.org/10.1210/jendso/bvaa046.353 |
Ejemplares similares
-
SAT252 Homozygous CYP24A1 Gene Mutation Induced Hypercalcemia During Pregnancy
por: Ankireddypalli, Anvitha Reddy, et al.
Publicado: (2023) -
LBSAT130 Hypercalcemia In Pregnancy Due To CYP24A1 Mutation
por: Agu, Chinyere, et al.
Publicado: (2022) -
Coexistent CYP24A1 and PHEX Gene Mutations With Hypervitaminosis D Plus Hypercalcemia Treated With Fluconazole
por: Bawden, David, et al.
Publicado: (2021) -
SAT-345 Etanercept Induced Hypercalcemia
por: Chaker, Bayan, et al.
Publicado: (2020) -
SAT-LB63 A Case of PTHrP-Negative Hypercalcemia of Malignancy
por: Murati, Jonila, et al.
Publicado: (2020)